NCT01475136View on ClinicalTrials.gov

A Study of LY2140023 in Hepatically-Impaired Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

37

Participants

Timeline

Start Date

November 30, 2011

Primary Completion Date

December 31, 2012

Study Completion Date

December 31, 2012

Conditions
Hepatic Insufficiency
Interventions
DRUG

LY2140023

Trial Locations (2)

8230

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Balatonfüred

81241

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Munich

Sponsors
All Listed Sponsors
lead

Denovo Biopharma LLC

INDUSTRY

NCT01475136 - A Study of LY2140023 in Hepatically-Impaired Participants | Biotech Hunter | Biotech Hunter